Newly released Medicare national coverage determinations are set to reshape the home ventilation landscape for chronic ...

Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring CPAP and patients ...

Continuous positive airway pressure (CPAP) has a greater effect on sleepiness and quality of life in younger vs older patients with OSA.

Hormonal shifts during perimenopause (and later, during menopause) disrupt the body’s ability to regulate temperature, ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...

AirSnore’s combination of a clinically proven mandibular advancement device and a unique blend of natural, science-backed ...

Innovent completes first patient dosing in seventh phase 3 trial (GLORY-OSA) of mazdutide in China with moderate-to-severe OSA & obesity: San Francisco, US Tuesday, June 17, 2025, ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which ...

Most labs ask patients to arrive around 8 p.m., with lights out around 10 p.m., depending on individual bedtime routines. The ...